(COLUMBUS, Ohio)—Ohio Governor Mike DeWine today signed Executive Order 2022-05D to suspend the normal rulemaking process to allow the Ohio Board of Pharmacy to classify a number of Benzimidazole-opioids as Schedule One drugs, meaning they have no accepted medical use in treatment and pose an imminent hazard to public health, safety, and welfare.
Original source can be found here.
